Christian Fermér

1.0k total citations
26 papers, 717 citations indexed

About

Christian Fermér is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Christian Fermér has authored 26 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Epidemiology and 5 papers in Oncology. Recurrent topics in Christian Fermér's work include Glycosylation and Glycoproteins Research (4 papers), Bacterial Infections and Vaccines (4 papers) and Genetic factors in colorectal cancer (3 papers). Christian Fermér is often cited by papers focused on Glycosylation and Glycoproteins Research (4 papers), Bacterial Infections and Vaccines (4 papers) and Genetic factors in colorectal cancer (3 papers). Christian Fermér collaborates with scholars based in Sweden, Norway and Finland. Christian Fermér's co-authors include Göte Swedberg, Eva Engvall, Ola Sköld, Bjørn‐Erik Kristiansen, Andrew Jenkins, Peter Rådström, Olle Nilsson, E Ask, Peter Nilsson and Mats Larhed and has published in prestigious journals such as The Lancet, PLoS ONE and Journal of Bacteriology.

In The Last Decade

Christian Fermér

26 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christian Fermér Sweden 14 252 208 202 148 140 26 717
Zachary Cusumano United States 13 190 0.8× 349 1.7× 94 0.5× 52 0.4× 54 0.4× 21 782
Seyed Fazlollah Mousavi Iran 14 215 0.9× 238 1.1× 141 0.7× 30 0.2× 102 0.7× 48 612
Thomas E. Grys United States 19 344 1.4× 244 1.2× 449 2.2× 87 0.6× 34 0.2× 63 1.2k
Runying Tian United States 3 250 1.0× 478 2.3× 214 1.1× 85 0.6× 104 0.7× 5 1.1k
Marian T. ten Kate Netherlands 22 336 1.3× 340 1.6× 430 2.1× 34 0.2× 90 0.6× 38 1.1k
Wim van Vianen Netherlands 18 247 1.0× 191 0.9× 276 1.4× 41 0.3× 47 0.3× 26 763
Zelin Cui China 17 153 0.6× 498 2.4× 194 1.0× 35 0.2× 131 0.9× 33 940
Martina Pontone Italy 9 73 0.3× 169 0.8× 193 1.0× 62 0.4× 44 0.3× 17 593
Keith Stephenson United Kingdom 21 133 0.5× 795 3.8× 401 2.0× 67 0.5× 92 0.7× 27 1.5k
Tobias Hertlein Germany 19 118 0.5× 428 2.1× 331 1.6× 37 0.3× 196 1.4× 35 829

Countries citing papers authored by Christian Fermér

Since Specialization
Citations

This map shows the geographic impact of Christian Fermér's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christian Fermér with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christian Fermér more than expected).

Fields of papers citing papers by Christian Fermér

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christian Fermér. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christian Fermér. The network helps show where Christian Fermér may publish in the future.

Co-authorship network of co-authors of Christian Fermér

This figure shows the co-authorship network connecting the top 25 collaborators of Christian Fermér. A scholar is included among the top collaborators of Christian Fermér based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christian Fermér. Christian Fermér is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caviglia, Gian Paolo, Maria Lorena Abate, P. Carucci, et al.. (2022). Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease. Current Oncology. 29(8). 5457–5465. 5 indexed citations
2.
Laitinen, A., Camilla Böckelman, Jaana Hagström, et al.. (2015). Podocalyxin as a Prognostic Marker in Gastric Cancer. PLoS ONE. 10(12). e0145079–e0145079. 23 indexed citations
3.
Hagström, Jaana, Hanna Mäenpää, Matti Välimäki, et al.. (2015). Expression of Stem Cell-associated Marker HES77 in Rectal Neuroendocrine Tumors.. PubMed. 35(7). 3767–72. 3 indexed citations
4.
Saukkonen, Kapo, Jaana Hagström, Harri Mustonen, et al.. (2015). Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma. PLoS ONE. 10(6). e0129012–e0129012. 29 indexed citations
5.
Kaprio, Tuomas, Jaana Hagström, Christian Fermér, et al.. (2014). A comparative study of two PODXL antibodies in 840 colorectal cancer patients. BMC Cancer. 14(1). 494–494. 13 indexed citations
6.
Kaprio, Tuomas, Christian Fermér, Jaana Hagström, et al.. (2014). Podocalyxin is a marker of poor prognosis in colorectal cancer. BMC Cancer. 14(1). 493–493. 32 indexed citations
7.
Stakenborg, Tim, Olivier Henry, Elin Borgen, et al.. (2011). LAB-ON-A-CHIP FOR THE MAGNETIC ISOLATION AND ANALYSIS OF CIRCULATING TUMOR CELLS. 1 indexed citations
8.
Paus, Elisabeth, Mads H. Haugen, Kjersti Flatmark, et al.. (2010). TD-11 workshop report: characterization of monoclonal antibodies to S100 proteins. Tumor Biology. 32(1). 1–12. 2 indexed citations
9.
Stakenborg, Tim, Chengxun Liu, Olivier Henry, et al.. (2010). Automated genotyping of circulating tumor cells. Expert Review of Molecular Diagnostics. 10(6). 723–729. 11 indexed citations
10.
Nilsson, Olle, et al.. (2008). Phage display for site-specific immunization and characterization of high-risk human papillomavirus specific E7 monoclonal antibodies. Journal of Immunological Methods. 337(2). 88–96. 7 indexed citations
11.
Fermér, Christian, et al.. (2007). Production and Characterization of Monoclonal Antibodies for Immunoassay of the Lung Cancer Marker proGRP. Tumor Biology. 28(2). 100–110. 28 indexed citations
12.
Ritzi, Marion, Klaus Stefan Drese, Wim Laureyn, et al.. (2007). Lab-on-chip for the Isolation and Characterization of Circulating Tumor Cells. Conference proceedings. 2007. 6446–6448. 4 indexed citations
13.
Fermér, Christian, Peter Nilsson, & Mats Larhed. (2003). Microwave-assisted high-speed PCR. European Journal of Pharmaceutical Sciences. 18(2). 129–132. 47 indexed citations
14.
Engvall, Eva, B. Brändström, A. Gunnarsson, et al.. (2002). Validation of a polymerase chain reaction/restriction enzyme analysis method for species identification of thermophilic campylobacters isolated from domestic and wild animals. Journal of Applied Microbiology. 92(1). 47–54. 34 indexed citations
15.
Fermér, Christian, et al.. (2002). Development and use of a simple polymerase chain reaction assay to screen for Helicobacter spp. and H. hepaticus in intestinal and fecal samples from laboratory mice.. PubMed. 52(6). 518–22. 5 indexed citations
17.
Fermér, Christian, Bjørn‐Erik Kristiansen, Ola Sköld, & Göte Swedberg. (1995). Sulfonamide resistance in Neisseria meningitidis as defined by site-directed mutagenesis could have its origin in other species. Journal of Bacteriology. 177(16). 4669–4675. 76 indexed citations
18.
Kristiansen, Bjørn‐Erik, Christian Fermér, Andrew Jenkins, et al.. (1995). PCR amplicon restriction endonuclease analysis of the chromosomal dhps gene of Neisseria meningitidis: a method for studying spread of the disease-causing strain in contacts of patients with meningococcal disease. Journal of Clinical Microbiology. 33(5). 1174–1179. 18 indexed citations
19.
Swedberg, Göte, Christian Fermér, & Ola Sköld. (1993). Point Mutations in the Dihydropteroate Synthase Gene Causing Sulfonamide Resistance. Advances in experimental medicine and biology. 338. 555–558. 27 indexed citations
20.
Kristiansen, Bjørn‐Erik, E Ask, Andrew Jenkins, et al.. (1991). Rapid diagnosis of meningococcal meningitis by polymerase chain reaction. The Lancet. 337(8757). 1568–1569. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026